Verastem (VSTM) Common Equity (2011 - 2026)

Verastem's Common Equity history runs 16 years deep, the most recent figure standing at $81.8 million for Q1 2026.

• On a quarterly basis, Common Equity rose 352.14% year-over-year to $81.8 million in Q1 2026; TTM through Mar 2026 was $81.8 million, a 352.14% increase from a year earlier, with the FY2025 full-year figure at $57.2 million, up 297.96% from the prior year.
• Common Equity climbed to $81.8 million in Q1 2026 per VSTM's latest filing, from $57.2 million in the prior quarter.
• Across five years, Common Equity topped out at $101.6 million in Q2 2023 and bottomed at -$32.4 million in Q1 2025.
• The 5-year median for Common Equity is $47.4 million (2022), against an average of $39.1 million.
• Across the five-year window, Common Equity plunged 240.38% in 2025 and surged 352.14% in 2026, its largest moves.
• Year by year, Common Equity stood at $47.4 million in 2022, then advanced by 21.07% to $57.4 million in 2023, then tumbled by 150.36% to -$28.9 million in 2024, then jumped by 297.96% to $57.2 million in 2025, then surged by 42.97% to $81.8 million in 2026.
• Per Business Quant, the three latest VSTM Common Equity figures stand at $81.8 million (Q1 2026), $57.2 million (Q4 2025), and -$15.5 million (Q3 2025).